ScholarIQanswers from OpenAlex

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

PaperCitations, authors & open-access status

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm have?

ScholarIQcitation count

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm has 249 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm published?

ScholarIQyear

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm has 2005 year in the ScholarIQ index.

What is the open-access status of Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm?

ScholarIQoa status

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm has closed oa status in the ScholarIQ index.

What is the DOI of Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm?

ScholarIQdoi

The DOI for Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm is on the source record.

What is the PMID of Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm?

ScholarIQpmid

The PMID for Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm is on the source record.

What is the OpenAlex record for Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm?

ScholarIQopenalex

The OpenAlex for Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial